vs

Side-by-side financial comparison of BrightSpire Capital, Inc. (BRSP) and STEM, INC. (STEM). Click either name above to swap in a different company.

BrightSpire Capital, Inc. is the larger business by last-quarter revenue ($83.2M vs $47.1M, roughly 1.8× STEM, INC.). BrightSpire Capital, Inc. runs the higher net margin — -17.3% vs -33.9%, a 16.6% gap on every dollar of revenue. On growth, BrightSpire Capital, Inc. posted the faster year-over-year revenue change (-0.4% vs -15.6%). Over the past eight quarters, STEM, INC.'s revenue compounded faster (36.1% CAGR vs -6.8%).

Oakley Capital Investments, is a large British investment trust focused on investments in mid-market companies in the business services, consumer, education and technology sectors. The company is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index.

StemCells, Inc. is a public biopharmaceutical company headquartered in Newark, California, that is developing purified human neural stem cells (HuCNS-SCs) in the hopes of treating central nervous system disorders and paralysis. StemCells' HuCNS-SCs have the ability to differentiate into the three main types of cells found in the central nervous system: neurons, astrocytes and oligodendrocytes.

BRSP vs STEM — Head-to-Head

Bigger by revenue
BRSP
BRSP
1.8× larger
BRSP
$83.2M
$47.1M
STEM
Growing faster (revenue YoY)
BRSP
BRSP
+15.2% gap
BRSP
-0.4%
-15.6%
STEM
Higher net margin
BRSP
BRSP
16.6% more per $
BRSP
-17.3%
-33.9%
STEM
Faster 2-yr revenue CAGR
STEM
STEM
Annualised
STEM
36.1%
-6.8%
BRSP

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BRSP
BRSP
STEM
STEM
Revenue
$83.2M
$47.1M
Net Profit
$-14.4M
$-16.0M
Gross Margin
48.9%
Operating Margin
-17.7%
Net Margin
-17.3%
-33.9%
Revenue YoY
-0.4%
-15.6%
Net Profit YoY
27.3%
68.8%
EPS (diluted)
$-0.11
$-4.40

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BRSP
BRSP
STEM
STEM
Q4 25
$83.2M
$47.1M
Q3 25
$83.9M
$38.2M
Q2 25
$85.9M
$38.4M
Q1 25
$77.6M
$32.5M
Q4 24
$83.5M
$55.8M
Q3 24
$88.2M
$29.3M
Q2 24
$91.4M
$34.0M
Q1 24
$95.8M
$25.5M
Net Profit
BRSP
BRSP
STEM
STEM
Q4 25
$-14.4M
$-16.0M
Q3 25
$984.0K
$-23.8M
Q2 25
$-23.1M
$202.5M
Q1 25
$5.3M
$-25.0M
Q4 24
$-19.7M
$-51.1M
Q3 24
$12.7M
$-148.3M
Q2 24
$-67.9M
$-582.3M
Q1 24
$-57.1M
$-72.3M
Gross Margin
BRSP
BRSP
STEM
STEM
Q4 25
48.9%
Q3 25
35.5%
Q2 25
33.4%
Q1 25
32.4%
Q4 24
-4.4%
Q3 24
21.2%
Q2 24
27.6%
Q1 24
-95.0%
Operating Margin
BRSP
BRSP
STEM
STEM
Q4 25
-17.7%
Q3 25
-1.7%
-33.6%
Q2 25
-54.5%
-34.8%
Q1 25
5.1%
-65.0%
Q4 24
-24.9%
-84.4%
Q3 24
13.2%
-493.2%
Q2 24
-74.9%
-1705.5%
Q1 24
-59.4%
-267.0%
Net Margin
BRSP
BRSP
STEM
STEM
Q4 25
-17.3%
-33.9%
Q3 25
1.2%
-62.2%
Q2 25
-26.9%
527.8%
Q1 25
6.9%
-76.9%
Q4 24
-23.7%
-91.6%
Q3 24
14.4%
-506.3%
Q2 24
-74.2%
-1712.6%
Q1 24
-59.6%
-283.9%
EPS (diluted)
BRSP
BRSP
STEM
STEM
Q4 25
$-0.11
$-4.40
Q3 25
$0.00
$-2.84
Q2 25
$-0.19
$-1.79
Q1 25
$0.04
$-0.15
Q4 24
$-0.16
$-15.29
Q3 24
$0.09
$-18.24
Q2 24
$-0.53
$-71.81
Q1 24
$-0.45
$-0.46

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BRSP
BRSP
STEM
STEM
Cash + ST InvestmentsLiquidity on hand
$66.8M
$48.9M
Total DebtLower is stronger
$2.5B
Stockholders' EquityBook value
$938.4M
$-249.4M
Total Assets
$3.6B
$308.9M
Debt / EquityLower = less leverage
2.63×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BRSP
BRSP
STEM
STEM
Q4 25
$66.8M
$48.9M
Q3 25
$113.4M
$43.1M
Q2 25
$154.3M
$40.8M
Q1 25
$200.9M
$58.6M
Q4 24
$302.2M
$56.3M
Q3 24
$263.8M
$75.4M
Q2 24
$203.3M
$89.6M
Q1 24
$221.5M
$112.8M
Total Debt
BRSP
BRSP
STEM
STEM
Q4 25
$2.5B
Q3 25
$2.2B
Q2 25
$2.3B
Q1 25
$2.3B
Q4 24
$2.5B
Q3 24
$2.6B
Q2 24
$2.5B
Q1 24
$2.6B
Stockholders' Equity
BRSP
BRSP
STEM
STEM
Q4 25
$938.4M
$-249.4M
Q3 25
$976.4M
$-235.7M
Q2 25
$994.4M
$-214.1M
Q1 25
$1.0B
$-417.5M
Q4 24
$1.0B
$-398.4M
Q3 24
$1.1B
$-344.1M
Q2 24
$1.1B
$-203.2M
Q1 24
$1.2B
$371.6M
Total Assets
BRSP
BRSP
STEM
STEM
Q4 25
$3.6B
$308.9M
Q3 25
$3.3B
$362.6M
Q2 25
$3.4B
$379.2M
Q1 25
$3.6B
$405.1M
Q4 24
$3.7B
$437.4M
Q3 24
$3.8B
$537.8M
Q2 24
$3.8B
$691.5M
Q1 24
$3.9B
$1.3B
Debt / Equity
BRSP
BRSP
STEM
STEM
Q4 25
2.63×
Q3 25
2.22×
Q2 25
2.27×
Q1 25
2.27×
Q4 24
2.38×
Q3 24
2.36×
Q2 24
2.28×
Q1 24
2.17×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BRSP
BRSP
STEM
STEM
Operating Cash FlowLast quarter
$73.0M
$8.2M
Free Cash FlowOCF − Capex
$55.1M
FCF MarginFCF / Revenue
66.2%
Capex IntensityCapex / Revenue
21.6%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$102.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BRSP
BRSP
STEM
STEM
Q4 25
$73.0M
$8.2M
Q3 25
$29.9M
$11.4M
Q2 25
$17.4M
$-21.3M
Q1 25
$10.5M
$8.5M
Q4 24
$103.4M
$-14.7M
Q3 24
$31.3M
$-9.4M
Q2 24
$22.9M
$-11.9M
Q1 24
$24.6M
$-621.0K
Free Cash Flow
BRSP
BRSP
STEM
STEM
Q4 25
$55.1M
Q3 25
$27.4M
Q2 25
$11.6M
Q1 25
$8.0M
Q4 24
$97.3M
Q3 24
$28.3M
Q2 24
$22.7M
Q1 24
$22.2M
FCF Margin
BRSP
BRSP
STEM
STEM
Q4 25
66.2%
Q3 25
32.7%
Q2 25
13.4%
Q1 25
10.3%
Q4 24
116.6%
Q3 24
32.1%
Q2 24
24.9%
Q1 24
23.2%
Capex Intensity
BRSP
BRSP
STEM
STEM
Q4 25
21.6%
Q3 25
2.9%
Q2 25
6.8%
Q1 25
3.2%
Q4 24
7.3%
Q3 24
3.4%
Q2 24
0.1%
Q1 24
2.5%
Cash Conversion
BRSP
BRSP
STEM
STEM
Q4 25
Q3 25
30.36×
Q2 25
-0.11×
Q1 25
1.97×
Q4 24
Q3 24
2.46×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons